Cospharm Inc is categorized under Chemical Laboratory, Except Testing in East Brunswick, NJ and active since 1997.
Cospharm Inc was established in 1997, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Chemical Laboratory, Except Testing business, which does work in the B2B market, and is classified as a Chemical Laboratory, Except Testing, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Dennis Chun at the company’s single location by writing to 33 Heyward Court, East Brunswick, New Jersey NJ 08816 or by phoning (732) 888-1588. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Cospharm Inc |
Contact Person: | Dennis Chun |
Address: | 33 Heyward Court, East Brunswick, New Jersey 08816 |
Phone Number: | (732) 888-1588 |
Website Address: | cospharm.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1997 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Chemical Laboratory, Except Testing |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Cospharm Inc was started in 1997 to provide professional Chemical Laboratory, Except Testing under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Dennis Chun for inquiries that concern Cospharm Inc by calling the company number (732) 888-1588, as your correspondence is most welcome. Additionally, the physical location of the single location of Cospharm Inc can be found at the coordinates 40.409144,-74.413188 as well as the street address 33 Heyward Court in East Brunswick, New Jersey 08816.
For its online presence, you may visit Cospharm Inc’s website at cospharm.com and engage with its social media outlets through on Twitter and on Facebook.